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Most of the patients have been treated for acute leukemia 
with allogeneic transplant. 
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Purpose or Objective: Breast cancer patients are among the 
long-term survivors of radiotherapy and therefore the long-
term cardiopulmonary toxicity due to the treatment should 
be reduced to a minimum. However, complication rates could 
be further increased when intramammary nodes are included 
in the target due to their proximity to the heart and the 
lungs. Several techniques could be used to decrease the dose 
to the normal tissues and consequently the rates of late 
complications, including proton beam radiotherapy and 
respiratory gating. This study aims to investigate the 
potential for normal tissue sparing for the treatment of 
intramammary nodes in breast cancer radiotherapy using 
scanned proton beams with or without respiratory gating. 
 
Material and Methods: The study was performed on CT-
datasets acquired from ten left-sided patients during 
enhanced inspiration gating (EIG) and free-breathing (FB). 
The patients were planned with intensity modulated proton 
therapy (IMPT) for locoregional breast treatment. The 
prescribed dose to the target was 50 GyRBE in 25 fractions, 
assuming an RBE of 1.1. Different plans were performed for 
breast and supraclavicular nodes respectively breast, 
supraclavicular and intramammary nodes (IMN). The 
implications of including IMN in the target volume were 
evaluated from the point of view of the doses to the organs 
at risk for cardiopulmonary complications. 
 
Results: Inclusion of the IMN in the target volume led to a 
small increase of the cardiopulmonary burden. Thus, in FB 
cases the average dose to the heart increased from 0.3 to 0.4 
GyRBE and the average dose to the lung increased from 6.1 
to 6.6 GyRBE, while the average dose to the left anterior 
descending artery (LAD) decreased from 4.1 to 3.8 GyRBE. 
For EIG cases the average dose to the heart was almost 
unchanged (0.2 GyRBE), the average dose to the lung 
increased from 6.9 to 7.4 GyRBE and the average dose to the 
LAD decreased from 3.3 to 2.6 GyRBE. Other dosimetric 
parameters of interest showed a similar trend when IMN were 
included in the target. These parameters are much lower 
than those that could be achieved in conventional 
radiotherapy with photons, especially with respect to the 
cardiovascular burden, irrespective of whether respiratory 
gating is used or not. 
 
Conclusion: The results of this study indicate that 
radiotherapy with scanned proton beams has the potential of 
significantly limit the cardiopulmonary burden compared to 
photon RT when including the IMN in breast cancer 
radiotherapy. 
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Purpose or Objective: Stereotactic ablative radiotherapy 
(SABR) for the lung primary and metastatic tumors aims to 
increase the local control, survival and quality of life. Deep 
inspiration breath hold (DIBH) using 4D CT for simulation 
minimizes respiratory motion and reduces the toxicity risk by 
decreasing margins. In this study, we aimed to compare the 
dosimetric results of different devices and techniques of 
SABR using volumetric arc therapy (VMAT) with DIBH in the 
lung tumors. 
 
Material and Methods: CT datasets of 7 patients with right-
sided lung cancer performed with RPM system (Varian, Palo 
Alto) was used. Median PTV was 13.2cc. Dose prescription 
objective was to cover 98% of the target volume by D98% 
which was 50 Gy/5 fractions. Four different VMAT plans were 
made on Eclipse TPS (Varian, Palo Alto) using AAA algorithm. 
Plan A consisted of TrueBeam,120HDMLC, 6MV-FFF, without 
jaw tracking, Plan B TrueBeam,120HDMLC, 6MV-FFF, with jaw 
tracking, Plan C TrueBeam,120HDMLC, 6MV, without jaw 
tracking, Plan D with Trilogy, 120MilleniumMLC, 6MV, without 
jaw tracking. Three partial arcs using 210 degrees were used 
to generate the plans under the same optimization 
conditions. Monitor Unit (MU), beam-on time (BOT), Gradient 
Index (GI), lung V20 and V5, dose at 2 cm from PTV (D2cm), 
PTV(Dmax) and PTV(Dmin) were assessed for comparison. 
Wilcoxon test was used for statistical evaluation. 
 
Results: No statistically significant differences were found 
for total MU, D2cm and PTV(Dmin) between the four plans. 
Mean PTV(Dmax) values were lower in Plan C with HDMLC 
compared to Plan D with MilleniumMLC (122.9%±3.9 vs 
126.8%±3.7, p=.018). At GI assessment; there was no 
significant difference between plans with and without jaw-
tracking. However, there was a significant difference 
between Plan C and Plan D (4.4±0.5 vs 4.8±0.6, p=.018); and 
between Plan A (FFF) and Plan C (FF) (4.2±0.4 vs 4.4±0.5, 
p=.018). V20 and V5 was lower in Plan C compared to Plan D 
(2.8%±1.5 vs 3.3%±1.5, p=.028 and 15.1%±5.3 vs 16.0%±5.6, 
p=.018).; V5 was lower in Plan A compared to Plan C 
(14.4%±5.1% vs 15.1%±5.3). BOT was significantly shorter 
between Plan A and Plan C (167.5 sec±20.4 vs 390.5 
sec±47.8, p=.018). 
 
Conclusion: In SABR with WMAT using DIBH, we observed 
some improvements by using HDMLC compared to 
MilleniumMLC and FFF compared to FF beams. However, we 
could not observe additional benefit with jaw tracking in the 
FFF mode. Major advantage of FFF was the shorter BOT, 
which may finally improve the patient compliance in SABR 
using DIBH technique. 
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Purpose or Objective: In locally advanced NSCLC Concurrent 
chemo/Radiation is the key most important treatment 
approach. However delivering adequate radiation dose to 
improve treatment results is limited by the tolerance of 
nearby structures (lungs, esophagus, heart etc…), and by the 
intrafractional uncertainties resulting from prolonged 
treatment time of the conventional techniques. We have 
compared VMATplanes Vs. 3D CRT in inoperable advanced 
lung cancer cases. 
 
Material and Methods: Ten cases of previously treated lung 
cancer with 3DCRT planes ( minimum of 4 beams) were 
replanned with VMAT optimization using 2 half arcs. Both 
planes were performed on Eclipse© planning system (version 
11) with AAA-algorithm and linear accelerator UNIQUE © of 
energy 6Mv , dose rate of 600 cGy/min , and 120 multileaf 
collimator. The dose was prescribed as 60Gy / 30fr to the 
CTV surrounded with margin of 1.5cm for the PTV. Plans 
were compared for coverage , avoidance of organs at risk , 
and total number of MU. 
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Results: The mean GTV volumes ranged from 149.44 to 
526.53 cc. VMAT plans show good results in comparison with 
3DCRT in both conformity index (0.81±0.09 Vs 0.68±0.07 
respectively, p-value of 0.009), and heterogeneity index 
(0.11±0.03 Vs 0.14±0.02, p value= 0.042). Furthermore, 
minimum doses to PTV in VMAT plans are higher than 3DCRT 
plans (57±1.22 Vs 55.1±0.86, p value= 0.001).  
In risk structures, the lung volume receiving 10Gy, 20Gy and 
30Gy were reduced in VMAT plans (with relative reduction of 
2.27%, p=0.002; 4.87%, p=0.001; 11.8% respectively). Mean 
lung dose was also reduced ( 15 Vs 17.69 ) but not 
statistically significant. V30 of the heart was reduced 
compared to 3DCRT (7.53±6.2 10.43±6.8 with p value of 
0.051). The maximum dose of esophagus with VMAT was 47.7 
Vs 48.69 with 3D CRT ( not statistically significant). 
Moreover, D 50 of the esophagus was less with VMAT ( 19.94 
Vs 23.63) with p value of 0.22. 
Regarding monitor units, the mean values were ( 
461.40±124.42 Vs 227.90±13.52) for VMAT and 3D CRT 
respectively.  
 
Conclusion: Inspite of large PTVs included in our study VMAT 
planes showed tendency toward reduction of mean and high 
lung dose and heart doses. Reduction in esophageal doses 
was not statistically significant , This was obtained without 
impairment of PTV coverage that was improved in some 
cases. VMAT for advanced lung cancer can help to improve 
therapeutic ratio and may open the door for dose escalation 
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Purpose or Objective: CSI is one of the most complex 
radiotherapy (RT) treatments. Conformal 3D RT techniques 
require many fields (field within field / segments) to achieve 
homogeneity and minimise doses to organs at risk (OAR) and 
involve field junctions. The planning process is time 
consuming and the actual treatment delivery is long, 
frequently exceeding 30 minutes. HT offers an excellent 
alternative with the ability to treat patients in supine 
position, without junctions and with better dose distribution. 
The aim of this study is to evaluate the use of HT in CSI with 
emphasis on dosimetric parameters and treatment duration. 
 
Material and Methods: Retrospective analysis of treatment 
planning and dosimetric indices was undertaken on seven 
patients who received cranio-spinal radiotherapy with HT at 
our centre. The HT plan was delivered using 51 beam angles 
per rotation, with a constant modulation factor of 2.0, field 
width of 5 cm and one of two pitches (0.43 or 0.28) to 
optimise treatment plans. An iterative inverse planning 
algorithm based on least squares minimization was used 
which optimises multi-leaf collimator at each beam angle. 
Dose was calculated by convolution and superposition. 
Patients were imaged daily covering different areas of the 
body and corrections applied for directional errors. Data 
analysis was done using descriptive statistics. 
 
Results: Helical tomotherapy plans for seven adult patients 
were analysed. Five patients had a haematological 
malignancy and two had a medulloblastoma. Five patients 
with a haematological diagnosis received a dose of 30Gy in 
1.5Gy/#. Two patients with medulloblastoma received 35 Gy 
delivered in 1.67Gy/#. Details of treatment planning and plan 
evaluation parameters of seven patients are presented in 
Table 1.  
 
 
Overall HT plans achieved excellent PTV coverage with mean 
V95 of 33.5 Gy for medullblastoma patients. The mean V95 
was 28.3 Gy for those with a haematological diagnosis. The 
mean homogeneity index was 1.0. Organs at risk doses were 
well below tolerances required. In particular averaged mean 
heart dose was 10.9±1.3, mean lung dose was 8.6±2.2 and 
mean liver dose was 9.8±1.2. The mean D50% for lung was 7.2 
Gy±3.8 and mean D10% was 20.2Gy±3.6. The mean D50% for 
the heart was 10.1Gy±1.3 and mean D10% was 14.7Gy±2.1. 
 
Conclusion: HT for CSI has many advantages including: the 
ability to treat patients in supine position, no need for 
junctions, excellent PTV coverage, low doses to OAR and 
shorter treatment time. 
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Purpose or Objective: Stereotactic radiosurgery of brain 
metastases requires highly conformal dose distributions. 
Besides beams setup, characteristics of the linear accelerator 
collimator may also play a role. In this study we compared 
the impact of leaf width on the dose outside the target for 
stereotactic radiosurgery of single brain metastases. 
 
Material and Methods: For 10 patients with one lesion, 
treatment plans were generated using two MLC types: Elekta 
Agilty with 0.5cm leaf width and Elekta MLCi2 with 1cm leaf 
width. Two VMAT arcs were used, one coplanar arc and one 
non-coplanar arc (couch 90˚). Five patients had a PTV 
volume ≤ 4 cm³ with a prescription dose of 24Gy in 1 
fraction, and 5 patients had a PTV volume between 4 and 14 
cm³ with a prescription dose of 18Gy in 1 fraction. All plans 
were required to fulfill clinical requirements: 
V100%Dpres>95%VPTV, D0<150%Dpres and OAR doses as low 
as possible and never above clinical constraints. The 
maximum dose in the PTV is kept the same per patient in 
both plans. The quality of the dose distribution outside the 
PTV was evaluated using the mean dose in two ring 
structures, adjacent to the PTV. 
 
Results: The mean dose was evaluated in the first 2 rings of 5 
mm around the PTV(table 1). The difference in mean dose for 
the small lesions(Dpres=24 Gy) of the first ring of 5 mm is 1.8 
Gy in favor of the Agility and 0.9 Gy for the larger 
lesions(Dpres=18 Gy)also in favor of the Agility. The 
difference is smaller for the larger lesions (figure1). Also for 
the second ring of 5 mm, adjacent to the first ring, the 
difference is is 1.1 Gy vs 0.8 Gy also in favor of the Agility.  
 
